Patient information guide

UroFill technique: penile filler approach and evidence

UroFill is a technique for placing hyaluronic acid around the penile shaft, not a separate HA product. Published results need to be read alongside their limitations.

AI tools

Summarize This Guide with AI

The page title, key topics and source link are passed to your selected tool in a prepared prompt.

On this page

What is UroFill?

An application technique based on placing hyaluronic acid filler in a defined tissue plane of the penile shaft.

Application plane

The target is the mobile space between the superficial Dartos tissue and the deeper Buck's fascia.

A staged approach

Contour and tissue response are reassessed at review. The decision about any further application follows that assessment.

Duration and limitations

HA can break down over time. Duration varies with the individual, product, tissue response and follow-up period.

Schematic cross-section

The intended anatomical plane

Tissue layers in the UroFill techniqueA simple medical diagram showing skin, Dartos, the target application plane and Buck's fascia from superficial to deep.SkinDartosTarget planeAreolar tissueBuck's fascia

Not drawn to scale. The actual thickness and mobility of the layers can vary between individuals.

Planning and follow-up

How the process progresses

  1. 1AssessmentAnatomy, previous procedures and expectations are considered.
  2. 2Initial applicationThe planned initial application is performed.
  3. 3ReviewDistribution and contour are assessed after swelling subsides.
  4. 4Further application if neededThe decision is based on the review findings.
  5. 5Follow-upTissue response and possible problems are monitored.

The UroFill name describes an approach to placing hyaluronic acid, or HA, around the penile shaft in a defined tissue plane, with staged reassessment of the contour. It does not identify a separate hyaluronic acid product. The commercial gel being used and its physical properties need to be discussed separately.

The intended change concerns shaft circumference. This does not create additional anatomical length or treat erectile dysfunction. Glans filler concerns the head of the penis, a different anatomical area with a separate evidence base, including discussion in premature ejaculation. A shared word such as filler should not blur those distinctions.

There is an intellectual-property history behind the technique. For someone considering a procedure, the practical questions concern the material, the placement plane, why a particular plan is proposed and how concerns afterward will be assessed. A technique name alone does not establish suitability.

The tissue plane and hydrodissection

Below the shaft skin and superficial Dartos tissue is a deeper layer called Buck’s fascia. Fascia is connective tissue surrounding anatomical structures. The described UroFill target is the mobile tissue plane between the Dartos and Buck fascial layers. Deeper blood vessels and nerves make recognition of the anatomy relevant to placement.

Hydrodissection means using injected fluid to separate adjacent tissue layers in a controlled way and define a potential space. Its inclusion in a protocol does not prove that every injection stays in the intended plane. It also does not remove complication risk. Examination and observation of tissue behaviour remain necessary.

UroFill does not rely on an entirely different filler material from other HA approaches. The described distinctions involve the anatomical plane, staged decisions about volume and review of distribution and contour. Other penile filler methods may share some of those principles. Direct, high-quality comparative research has not shown UroFill to be superior to other appropriately performed HA techniques.

For a different named protocol, the Androfill guide explains what its public description says and what cannot be established by comparing provider information. A technique description is not a controlled comparison of outcomes.

Staged treatment, modelling and sculpting

In a staged approach, the intended change is not automatically completed through a large volume at one visit. After the initial procedure, swelling and the distribution of HA are reassessed. Whether more material is appropriate is considered in light of those findings, not as a guaranteed next appointment.

Starting circumference cannot be converted directly into a personal millilitre requirement. Tissue capacity, previous procedures and the response after treatment also matter. The term staged does not by itself mean a person is suitable or the risk is low. There is no validated universal formula determining the amount for each visit or the total course.

Modelling refers to controlled adjustment of the placed material’s contour. Sculpting describes reconsidering the shape at review, sometimes with selective addition in an area judged deficient or asymmetric. These terms are not instructions to perform forceful massage at home. Any handling advice must relate to the actual gel, timing and clinical findings.

The planner below compares circumference measurements. It cannot determine filler volume or a schedule of procedures. The separate guide to penile filler amounts explains why an anatomical assessment cannot be replaced by a geometric calculation.

What UroFill-specific publications report

A 2024 conference abstract presented retrospective results from 300 men treated with the UroFill technique. The reported mean total HA volume was 16.5 mL and the mean number of injection sessions was 3.85. These are observations from that cohort, not a proposed amount or number of visits for a reader.

The abstract reported mean filler retention of approximately 90% at twelve months. That result comes from a retrospective series reported in a conference supplement. It is not a personal retention forecast, nor a guarantee for subsequent years. The authors disclosed industry relationships, including UroFill. Those relationships and the study design belong in the interpretation of the result.

A second 2024 conference abstract examined retrospective data from 563 patients across six providers. Local skin infections were reported in 28 men, approximately 5%. There was no control group, and the providers worked within the same UroFill training and protocol system. The series documents that complications can occur; it does not demonstrate fewer complications than another technique.

A 2026 systematic review and meta-analysis considered 23 studies involving 2,620 people across penile augmentation approaches. Products, techniques, measurements and follow-up periods differed. Cross-material comparisons were indirect; the review cannot establish that UroFill is better than another HA protocol. A pooled result across heterogeneous procedures should not be treated as a brand-specific risk estimate.

The EAU guideline identifies limited evidence for girth interventions and calls for discussion of benefits and risks. ICSM recommendations also emphasise selection, counselling and the shortage of long-term data. The SMSNA position statement urges further safety and efficacy evaluation of injectable HA and similar temporary materials within approved research protocols.

Migration and other complications

Targeting an anatomical plane does not reduce the possibility of migration to zero. HA can move within tissue or collect unevenly. In uncircumcised men, foreskin and distal tissue mobility need consideration when assessing swelling and distribution. This feature alone does not establish that a procedure is impossible, but it can affect planning and follow-up.

Circumcision status should not alter the circumference arithmetic in the planner. It is a clinical consideration during examination, not a mathematical multiplier. A target measurement does not determine what is appropriate to inject into a particular person’s tissues.

Reported problems after shaft HA include swelling, bruising, tenderness, uneven contour, asymmetry, nodules, migration and infection. Very superficial placement can cause visible irregularity or colour changes. Increasing pain, pronounced discolouration, rapidly progressive swelling, discharge or fever needs assessment without waiting for a routine review.

An early uneven appearance is not enough to diagnose migration at home. Swelling can create a similar impression. Describe when it started and how it has changed rather than trying to manipulate the material yourself. The risks and recovery guide discusses the distinction between routine recovery and findings requiring review.

Hyaluronidase is an enzyme that can reduce HA in selected situations, such as some contour irregularities or excess material. It does not mean every problem can be reversed with one injection. Infection, impaired tissue circulation, pronounced inflammation or a non-HA product calls for a different assessment. The actual material and diagnosis need to be established first.

Duration and the meaning of FDA approval

HA is biodegradable, and the visible or measurable effect may diminish over time. Product characteristics, placement, total material, tissue response and follow-up all influence interpretation. The approximately 90% twelve-month mean reported in the UroFill series cannot establish an individual result over several years. Longer commercial claims do not carry the same weight as independent comparative follow-up.

An HA product approved by the US FDA for a particular facial or hand indication is not thereby approved for injection into the penile shaft. Approval applies to the product and its specified use. The FDA’s dermal filler information lists particular facial areas and the back of the hand; penile girth enhancement is not an approved indication. The phrase FDA-approved penile filler would therefore misrepresent that distinction.

Suitability is not decided by size alone

Examination considers the existing circumference and shape, skin mobility, circumcision status, earlier fillers or surgery, infection, curvature and the change being sought. New pain or erection difficulty should be assessed for its own cause rather than folded into a cosmetic plan. Earlier product records can help when examining a new firm area or asymmetry.

Intense preoccupation with measurements or appearance can also affect what is appropriate. Body dysmorphic disorder and penile dysmorphic concerns involve disproportionate distress about a perceived defect. Guidelines support psychological assessment where indicated, including when dimensions are within ordinary ranges. The aim is to avoid applying an intervention to a problem it is unlikely to resolve.

A consultation can lead to no procedure, a more limited goal or assessment of another concern first. To discuss your anatomy and previous treatments, you can contact the practice. Bring any available product and procedure records so that the discussion is based on what was actually used.

Compare measurements

Penile Circumference Planner

This tool is designed only to visualise the intended change in circumference. The amount of filler used is determined by anatomical assessment and the treatment plan.

Current and target circumference diagramThe dark inner ring represents the current circumference; the gold outer ring represents the target circumference.+1.0 cmcircumference difference
Current circumferenceTarget circumference
Current circumference
11.5 cm
Target circumference
12.5 cm
Circumference change
+1.0 cm
Sources8 sources

Cookies required for site functions are always on. You can choose the other categories.

CallWhatsAppAppointment